GSA Capital Partners’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $289K | Buy |
+79,024
| New | +$289K | 0.02% | 1279 |
|
2025
Q1 | – | Sell |
-354,154
| Closed | -$1.13M | – | 1963 |
|
2024
Q4 | $1.13M | Sell |
354,154
-419,393
| -54% | -$1.34M | 0.08% | 326 |
|
2024
Q3 | $2.21M | Sell |
773,547
-111,174
| -13% | -$318K | 0.17% | 96 |
|
2024
Q2 | $2.48M | Buy |
884,721
+353,503
| +67% | +$990K | 0.17% | 86 |
|
2024
Q1 | $1.51M | Buy |
531,218
+269,315
| +103% | +$765K | 0.12% | 219 |
|
2023
Q4 | $1.07M | Sell |
261,903
-352,665
| -57% | -$1.44M | 0.09% | 356 |
|
2023
Q3 | $1.95M | Sell |
614,568
-94,642
| -13% | -$301K | 0.17% | 115 |
|
2023
Q2 | $2.36M | Sell |
709,210
-16,348
| -2% | -$54.3K | 0.24% | 30 |
|
2023
Q1 | $1.55M | Buy |
725,558
+522,162
| +257% | +$1.11M | 0.15% | 141 |
|
2022
Q4 | $547K | Buy |
203,396
+191,407
| +1,597% | +$515K | 0.07% | 548 |
|
2022
Q3 | $39K | Sell |
11,989
-22,391
| -65% | -$72.8K | 0.01% | 1435 |
|
2022
Q2 | $168K | Buy |
34,380
+21,530
| +168% | +$105K | 0.03% | 1114 |
|
2022
Q1 | $98K | Buy |
+12,850
| New | +$98K | 0.01% | 1297 |
|
2020
Q4 | – | Sell |
-16,953
| Closed | -$65K | – | 1499 |
|
2020
Q3 | $65K | Buy |
+16,953
| New | +$65K | 0.01% | 1170 |
|